Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

280 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Baseline feature of a randomized trial assessing the effects of disease management programs for the prevention of recurrent ischemic stroke.
Fukuoka Y, Hosomi N, Hyakuta T, Omori T, Ito Y, Uemura J, Kimura K, Matsumoto M, Moriyama M; DMP Stroke Trial Investigators. Fukuoka Y, et al. Among authors: hosomi n. J Stroke Cerebrovasc Dis. 2015 Mar;24(3):610-7. doi: 10.1016/j.jstrokecerebrovasdis.2014.10.007. Epub 2015 Jan 6. J Stroke Cerebrovasc Dis. 2015. PMID: 25576351 Free article. Clinical Trial.
Features of patients with transient monocular blindness: a multicenter retrospective study in Japan.
Tanaka K, Uehara T, Kimura K, Okada Y, Hasegawa Y, Tanahashi N, Suzuki A, Takagi S, Nakagawara J, Arii K, Nagahiro S, Ogasawara K, Nagao T, Uchiyama S, Matsumoto M, Iihara K, Toyoda K, Minematsu K; Japan TIA Research Group 2009-2011. Tanaka K, et al. J Stroke Cerebrovasc Dis. 2014 Mar;23(3):e151-5. doi: 10.1016/j.jstrokecerebrovasdis.2013.09.017. Epub 2013 Oct 19. J Stroke Cerebrovasc Dis. 2014. PMID: 24144597
Cardiovascular event rates in patients with cerebrovascular disease and atherothrombosis at other vascular locations: results from 1-year outcomes in the Japanese REACH Registry.
Uchiyama S, Goto S, Matsumoto M, Nagai R, Origasa H, Yamazaki T, Shigematsu H, Shimada K, Yamada N, Bhatt DL, Steg PG, Ikeda Y; REduction of Atherothrombosis for Continued Health Registry Investigators. Uchiyama S, et al. J Neurol Sci. 2009 Dec 15;287(1-2):45-51. doi: 10.1016/j.jns.2009.09.011. Epub 2009 Oct 7. J Neurol Sci. 2009. PMID: 19815240
Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial.
Shinohara Y, Katayama Y, Uchiyama S, Yamaguchi T, Handa S, Matsuoka K, Ohashi Y, Tanahashi N, Yamamoto H, Genka C, Kitagawa Y, Kusuoka H, Nishimaru K, Tsushima M, Koretsune Y, Sawada T, Hamada C; CSPS 2 group. Shinohara Y, et al. Lancet Neurol. 2010 Oct;9(10):959-68. doi: 10.1016/S1474-4422(10)70198-8. Epub 2010 Sep 15. Lancet Neurol. 2010. PMID: 20833591 Clinical Trial.
Prospective Observational Study for the Comparison of Screening Methods Including Tongue Pressure and Repetitive Saliva Swallowing With Detailed Videofluoroscopic Swallowing Study Findings in Patients With Acute Stroke.
Nakamori M, Imamura E, Maetani Y, Yoshida M, Yoshikawa M, Nagasaki T, Masuda S, Kayashita J, Mizoue T, Wakabayashi S, Maruyama H, Hosomi N. Nakamori M, et al. Among authors: hosomi n. J Am Heart Assoc. 2024 Feb 6;13(3):e032852. doi: 10.1161/JAHA.123.032852. Epub 2024 Jan 31. J Am Heart Assoc. 2024. PMID: 38293925 Free PMC article.
"KAIZEN" method realizing implementation of deep-learning models for COVID-19 CT diagnosis in real world hospitals.
Okada N, Umemura Y, Shi S, Inoue S, Honda S, Matsuzawa Y, Hirano Y, Kikuyama A, Yamakawa M, Gyobu T, Hosomi N, Minami K, Morita N, Watanabe A, Yamasaki H, Fukaguchi K, Maeyama H, Ito K, Okamoto K, Harano K, Meguro N, Unita R, Koshiba S, Endo T, Yamamoto T, Yamashita T, Shinba T, Fujimi S. Okada N, et al. Among authors: hosomi n. Sci Rep. 2024 Jan 19;14(1):1672. doi: 10.1038/s41598-024-52135-y. Sci Rep. 2024. PMID: 38243054 Free PMC article.
280 results